Cargando…

Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up

Generally, the dysfunction or failure of bioprosthetic heart valves (BHVs) is managed by replacement surgery. In the case of tricuspid valve dysfunction, re-do surgery is rarely attempted because of the critically high risk of developing pulmonary hypertension, pulmonary embolism, and intraoperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Mussayev, Abdurashid, Alimbayev, Serik, Tanaliev, Nursultan, Kuanyshbek, Aidyn, Marat, Aripov, Lesbekov, Timur, Raissov, Yerkezhan, Sadykova, Aigerim, Kamila, Askarovna Kenzhebayeva, Mukarov, Murat, Pya, Yuriy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361752/
https://www.ncbi.nlm.nih.gov/pubmed/37485262
http://dx.doi.org/10.3389/fcvm.2023.1152280
_version_ 1785076278274031616
author Mussayev, Abdurashid
Alimbayev, Serik
Tanaliev, Nursultan
Kuanyshbek, Aidyn
Marat, Aripov
Lesbekov, Timur
Raissov, Yerkezhan
Sadykova, Aigerim
Kamila, Askarovna Kenzhebayeva
Mukarov, Murat
Pya, Yuriy
author_facet Mussayev, Abdurashid
Alimbayev, Serik
Tanaliev, Nursultan
Kuanyshbek, Aidyn
Marat, Aripov
Lesbekov, Timur
Raissov, Yerkezhan
Sadykova, Aigerim
Kamila, Askarovna Kenzhebayeva
Mukarov, Murat
Pya, Yuriy
author_sort Mussayev, Abdurashid
collection PubMed
description Generally, the dysfunction or failure of bioprosthetic heart valves (BHVs) is managed by replacement surgery. In the case of tricuspid valve dysfunction, re-do surgery is rarely attempted because of the critically high risk of developing pulmonary hypertension, pulmonary embolism, and intraoperative mortality. Hence, transcatheter tricuspid repair and replacement procedures are preferred. More recently, transcatheter valve-in-valve (ViV) treatments have gained importance because of their less invasiveness, especially for patients with prior surgeries. Encouraging evidence of the safety and effectiveness of a novel balloon-expandable (BE) transcatheter heart valve (THV)—the Myval THV—has been reported for ViV procedures. Here, we present a case-series of 5 patients, in whom tricuspid ViV procedure was performed using BE Myval THV, implanted supra-annularly by anchoring onto the deteriorated BHV. This case-series details the procedural steps to prevent in-hospital adverse events and early (30-day) mortality and the challenges during tricuspid ViV interventions.
format Online
Article
Text
id pubmed-10361752
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103617522023-07-22 Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up Mussayev, Abdurashid Alimbayev, Serik Tanaliev, Nursultan Kuanyshbek, Aidyn Marat, Aripov Lesbekov, Timur Raissov, Yerkezhan Sadykova, Aigerim Kamila, Askarovna Kenzhebayeva Mukarov, Murat Pya, Yuriy Front Cardiovasc Med Cardiovascular Medicine Generally, the dysfunction or failure of bioprosthetic heart valves (BHVs) is managed by replacement surgery. In the case of tricuspid valve dysfunction, re-do surgery is rarely attempted because of the critically high risk of developing pulmonary hypertension, pulmonary embolism, and intraoperative mortality. Hence, transcatheter tricuspid repair and replacement procedures are preferred. More recently, transcatheter valve-in-valve (ViV) treatments have gained importance because of their less invasiveness, especially for patients with prior surgeries. Encouraging evidence of the safety and effectiveness of a novel balloon-expandable (BE) transcatheter heart valve (THV)—the Myval THV—has been reported for ViV procedures. Here, we present a case-series of 5 patients, in whom tricuspid ViV procedure was performed using BE Myval THV, implanted supra-annularly by anchoring onto the deteriorated BHV. This case-series details the procedural steps to prevent in-hospital adverse events and early (30-day) mortality and the challenges during tricuspid ViV interventions. Frontiers Media S.A. 2023-07-04 /pmc/articles/PMC10361752/ /pubmed/37485262 http://dx.doi.org/10.3389/fcvm.2023.1152280 Text en © 2023 Mussayev, Alimbayev, Tanaliev, Kuanyshbek, Aripov, Lesbekov, Raissov, Sadykova, Kamila, Mukarov and Pya. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Mussayev, Abdurashid
Alimbayev, Serik
Tanaliev, Nursultan
Kuanyshbek, Aidyn
Marat, Aripov
Lesbekov, Timur
Raissov, Yerkezhan
Sadykova, Aigerim
Kamila, Askarovna Kenzhebayeva
Mukarov, Murat
Pya, Yuriy
Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up
title Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up
title_full Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up
title_fullStr Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up
title_full_unstemmed Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up
title_short Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up
title_sort case report: transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361752/
https://www.ncbi.nlm.nih.gov/pubmed/37485262
http://dx.doi.org/10.3389/fcvm.2023.1152280
work_keys_str_mv AT mussayevabdurashid casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup
AT alimbayevserik casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup
AT tanalievnursultan casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup
AT kuanyshbekaidyn casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup
AT marataripov casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup
AT lesbekovtimur casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup
AT raissovyerkezhan casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup
AT sadykovaaigerim casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup
AT kamilaaskarovnakenzhebayeva casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup
AT mukarovmurat casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup
AT pyayuriy casereporttranscathetertricuspidvalveinvalveimplantationusingnovelballoonexpandableaorticvalvewith1yearfollowup